GlobeNewswire by notified

VIRBAC: growth in revenue in the first half of 2022 of +12.0% at comparable exchange rates (+16.4% at real rates), driven by good performance in all areas

Share
KEY FIGURES
Revenue in first half of 2022 -Provisional



€616.4 million
Growth at constant exchange rates
and scope 1




+12.0% including

companion animals +14.2%

food-producing animals +9.9%
Growth at constant
exchange rates



+12.0%

Overall
change




+16.4%


1 Growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in question and the indicator for the previous financial year on the basis of identical exchange rates (the exchange rate used is the previous financial year), and excluding change in scope, by calculating the indicator for the financial year in question on the basis of the scope of consolidation for the previous financial year.


Quarterly consolidated revenue
Our second-quarter revenue reached €298.3 million, or a +13.5% increase compared to the same period in 2021. At constant exchange rates, growth was +7.8%, driven by good performance in both the companion animals and food producing animals segments, in a context of market slowdown. It should be noted that our actual performance for the quarter was favorably impacted by the appreciation of certain currencies, such as the US dollar, the Indian rupee, the Brazilian real, and the Mexican peso. At area level, our growth is mainly driven by the performance of the United States, particularly in the dental and dermatology ranges and recently launched products range (Clomicalm, Itrafungol, the petfood and the food producing animals range), by that of the Asia-Pacific zone, where India and Australia continue to benefit from a favorable momentum, and finally Latin America, driven by double-digit growth in Brazil and Mexico.


Cumulative consolidated revenue at the end of June
For the first half of the year overall, our revenues were €616.4 million, compared with €529.4 million, representing an overall increase of +16.4% compared with the same period in 2021. Adjusted for the favorable impact of exchange rates, revenue shows growth of +12.0%. This growth benefited in part from a favorable baseline effect representing 1 point of growth in revenue, attributable to new products acquired starting in the second quarter of 2021.

All areas are growing organically at the end of June. It should be noted, however, that double-digit growth in Europe has stalled in the last quarter, due to the slowdown in the market as anticipated in our annual outlook. Thus, the sales in this area increased by +6.8% at real rates (+6.2% at constant rates), thanks mainly to the contribution of the United Kingdom, France and Italy. The area is supported by the strong dynamism of companion animals ranges (in particular petfood, specialties, and vaccines), which compensate for the withdrawal of ranges intended for food producing animals. In Asia-Pacific, the development at real rates is +19.8% (+15% at constant exchange rates). Australia and India are driving growth in the region, generating more than 85% of the latter, in particular on products destined for cattle, which makes it possible to largely compensate for the withdrawal of China, which was heavily impacted by lockdowns at the beginning of the year and which, despite a rebound since May, remains down at the end of June. In Latin America, activity grew by +25.1% at real rates (+14.6% at constant exchange rates), thanks in particular to contributions from Brazil and Mexico. Finally, in the United States, activity increased by +32.2% (+19.9% at constant exchange rates). It benefits from sustained sales on new products launched in 2021 (Clomicalm and Itrafungol) and those launched in early 2022 (petfood, and Tulissin for the food producing animals segment), as well as good performance on the dental and dermatology ranges.


In terms of species, revenue in the companion animal segment grew overall by +17.9% at real rates (+14.2% at constant exchange rates), mainly driven by very good double-digit growth in the petfood, specialty, dermatology and hygiene ranges, as well as vaccines for dogs and cats. The food producing animals segment also showed strong growth of +15.0% at real rates (+9.9% at constant exchange rates), mainly driven by the ruminant sector (+14.2% at constant exchange rates); and the aquaculture segment (+5.1% at constant rates) compared to the same period in 2021.

Covid-19 health crisis and the war in Ukraine
We continue to face significant production, logistical and supply constraints with regard to certain intermediaries, and more recently, significant inflationary impacts on our costs (energy, raw materials, transportation, etc.).


Outlook
The activity in the first half of the year reinforces our perspective. Revenue growth at constant rates and scope should be in the range of 5% to 10%. The ratio of “current operating profit before depreciation of assets arising from acquisitions” to “revenue” should be around 15% at constant exchange rates, despite the inflationary impacts (with a deliberate overinvestment in R&D of approximately 1 percentage point of revenue compared to 2021). Finally, our debt relief should be around €60 million, excluding dividends, at constant scope and exchange rates.


CONSOLIDATED FIGURES
Non-audited figures 
in millions of euros
20222021GrowthGrowth 
at constant exchange rates 1
Growth 
at constant exchange rates and scope 1
First quarter revenue318.1266.5+19.3%+16.2%+16.2%
Second quarter revenue298.3262.9+13.5%+7.8%+7.8%
Revenue for first half year616.4529.4+16.4%+12.0%+12.0%





A lifelong commitment to animal health

At Virbac, we provide innovative solutions to veterinarians, farmers and animal owners in more than 100 countries around the world. Covering more than 50 species, our range of products and services enables us to diagnose, prevent and treat the majority of pathologies. Every day, we are committed to improving the quality of life of animals and to shaping the future of animal health together.

Virbac: NYSE Euronext - compartment A – ISIN code: FR0000031577 / MNEMO: VIRP
Financial Affairs Department: tel. 04 92 08 71 32 - email: finances@virbac.com - Website: corporate.virbac.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Tenaris Files 2023 Annual Report on Form 20-F28.3.2024 17:47:45 CET | Press release

LUXEMBOURG, March 28, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announces that it has filed today its Annual Report on Form 20-F for the year ended December 31, 2023, with the U.S. Securities and Exchange Commission (SEC). The annual report can be downloaded from the SEC’s website at www.sec.gov, and is available on Tenaris’s website at ir.tenaris.com. Holders of Tenaris’s shares and ADSs, and any other interested parties, may request a hard copy of the annual report, free of charge, through our website at ir.tenaris.com/tools/printed-materials. Tenaris is a leading global supplier of steel tubes and related services for the world’s energy industry and certain other industrial applications. Giovanni Sardagna Tenaris 1-888-300-5432 www.tenaris.com

International Petroleum Corporation Updated Share Capital28.3.2024 17:30:00 CET | Press release

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) reports the following, in accordance with the Swedish Financial Instruments Trading Act: Following the cancellation of 445,000 common shares repurchased by IPC under the normal course issuer bid / share repurchase program, the total number of issued and outstanding common shares of the Corporation is 125,438,160 common shares with voting rights as at March 28, 2024 and IPC holds no common shares in treasury. International Petroleum Corp. (IPC) is an international oil and gas exploration and production company with a high quality portfolio of assets located in Canada, Malaysia and France, providing a solid foundation for organic and inorganic growth. IPC is a member of the Lundin Group of Companies. IPC is incorporated in Canada and IPC’s shares are listed on the Toronto Stock Exchange (TSX) and the Nasdaq Stockholm exchange under the symbol "IPCO". For further information, please contact: Rebecca

Subsea 7 S.A. - Seaway7 awarded contract offshore Poland28.3.2024 17:15:00 CET | Press release

Luxembourg – 28 March 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award to Seaway7, part of the Subsea7 Group, of a sizeable¹ contract by PGE Polska Grupa Energetyczna and Ørsted for the transport and installation of the substations for the Baltica 2 wind farm, offshore Poland. Seaway7’s scope includes the transport and installation of four substations. Offshore activity is scheduled to take place in 2026 utilising both our heavy lift and heavy transportation vessels. Baltica 2 is a 50:50 joint venture between PGE Polska Grupa Energetyczna and Ørsted. The wind farm, with a capacity of around 1.5 GW, will be located in the Polish sector of the Baltic Sea around 40 kilometres from shore at its closest point. Maria Eidesvik, VP for Europe and US at Seaway7 said: “This is our second contract award in the emerging Polish market and we are pleased to be taking a role in developing offshore wind in this key location. With this project we also look forward to continu

Meltwater partners with leading digital agency Social Factor28.3.2024 17:00:00 CET | Press release

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Meltwater, a leading global provider of media, social and consumer intelligence, today announces a new partnership with Social Factor, a global digital agency focusing on social CRM and strategy. With this partnership, Meltwater and Social Factor customers will be able to leverage the best of Meltwater’s social analytics and social media management solutions alongside Social Factor’s specialization in social media operations and community management. Social Factor helps enterprise-level clients turn digital chaos into human connection through content moderation, community management, analytical data, governance, training, and security. They have deep expertise working with innovative technology solutions to foster customer engagement on behalf of Fortune 500 companies and other large, global enterprises. The Meltwater social listening and social media management solutions help teams to stay on top of conversations about their company, i

International Petroleum Corp. Annual General Meeting to be held on May 8, 202428.3.2024 17:00:00 CET | Press release

International Petroleum Corporation (“IPC” or the “Corporation”) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that its Annual General Meeting (the “Meeting”) of holders of common shares (“Shareholders”) will be held at the offices of Blake, Cassels and Graydon LLP, Suite 3500, 855 - 2nd Street S.W., Calgary, Alberta, Canada T2P 4J8 on Wednesday, May 8, 2024 at 8:00 a.m. (Mountain time), for the following purposes: To receive the audited consolidated financial statements of the Corporation for the financial year ended December 31, 2023 and accompanying report of the auditor;To set the number of directors of the Corporation at eight;To elect the eight nominees of the Corporation standing for election as directors of the Corporation to hold office until the next annual meeting of Shareholders or until his or her successor is duly elected or appointed;To appoint PricewaterhouseCoopers SA, as the auditor of the Corporation, to hold office until the next annual meeting of Shareholder

HiddenA line styled icon from Orion Icon Library.Eye